Integra Lifesciences Holdings Corp., of Plainsboro, N.J., completed a multicenter trial evaluating the safety and effectiveness of Integra Dermal Regeneration Template, its bilayer skin replacement system designed to help close wounds and regenerate skin cells for the treatment of diabetic foot ulcers.